Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21844547 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1) : Multi-centre, Prospective, Randomized Controlled Study
Condition: Influenza
Interventions: Drug: oseltamivir;   Other: blank;   Drug: chinese medicinal herbs;   Drug: oseltamivir and chinese medicinal herbs

Indicates status has not been verified in more than two years